Periodontal Treatment Associated With Hyperbaric Oxygen Therapy

NCT ID: NCT00955643

Last Updated: 2009-08-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2002-03-31

Study Completion Date

2003-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluation of the clinical effect of hyperbaric oxygen therapy (HBOT) adjunctively to scaling and root planing (SRP) in the treatment of severe case of chronic periodontitis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Materials and Methods: In 20 patients diagnosed with severe generalized chronic periodontitis (pockets\>7mm) with bleeding on probing, SRP was rendered in all pockets. Additionally, five consecutive hyperbaric sessions were administered in 10 patients after random allocation (SRP+HBOT). Clinical parameters were assessed at baseline up to 6 months: plaque index (PI), bleeding on probing, probing depth, clinical attachment level and BANA test.

Results: SRP+HBOT resulted in greater probing reduction and attachment gain than SRP alone 3 months after treatment (p\<0.001). The BANA test was negative after 1 week only for sites in the SRP+HBOT group (p\<0.05). However SRP+HBOT failed to show a significant difference from SRP group after 3 months were all BANA sites became negative (p\>0.05).

Conclusion: These preliminary data suggest that hyperbaric oxygen therapy had a short-term beneficial effect on pocket reduction and bacterial elimination, and may be considered a potential therapy option to improve the clinical outcomes of scaling in severe cases of chronic periodontitis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Periodontal Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

hyperbaric therapy

Hyperbaric therapy by oxygen

Group Type EXPERIMENTAL

oxygen

Intervention Type OTHER

dental scaling and root planing

dental scaling and cleaning

Group Type EXPERIMENTAL

other

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

oxygen

Intervention Type OTHER

other

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* This preliminary (pilot) study was designed with twenty subjects (12 men, 8 women, mean age 37.3 years) selected from a pool of 360 patients referred to the Periodontal Clinic of the School of Dentistry at Bahian Science Foundation (FBDC, Bahia, Brazil).
* The patients had an initial diagnosis of severe generalized chronic periodontitis (AAP 1999).

Exclusion Criteria

* Patients were excluded according to the following criteria:

* smoking
* pregnancy or lactation
* antibiotics or periodontal treatment within the last 6 months
* a diagnosis of aggressive periodontitis
* trauma from occlusion or endodontic lesions
* The only absolute contraindication to hyperbaric oxygen therapy was from patients with untreated pneumothorax
* Relative contraindications were considered:

* upper respiratory infections
* high fevers
* emphysema with CO2 retention
* historic of thoracic surgery
* malignant disease and middle ear barotrauma
* Patients taking or have recently taken the following drugs:

* doxorubicin (Adriamycin®)
* disulfiram (Antabuse®)
* Cis-platinum and mafenide acetate (Sulfamylon®).
Minimum Eligible Age

30 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Escola Bahiana de Medicina e Saude Publica

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Bahiana

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

EBMSP Central Clinic

Salvador, Estado de Bahia, Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HBOT900208-06

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.